Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
暂无分享,去创建一个
[1] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[2] V. Torri,et al. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Mate,et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. , 1994, The New England journal of medicine.
[4] H. Uchino,et al. DEPARTMENT OF INTERNAL MEDICINE , 1966 .
[5] J. Glanville,et al. Searching for Studies , 2008 .
[6] G. T. ten Velde,et al. Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] H. Kato,et al. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). , 2003, The Journal of thoracic and cardiovascular surgery.
[8] E. Lemarié,et al. A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial). , 2013, European journal of cancer.
[9] R Brian Haynes,et al. Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE. , 2006, Journal of the Medical Library Association : JMLA.
[10] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[11] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[12] E L Kaplan. NON-PARAMETRIC ESTIMATION FROM INCOMPLETE OBSERVATION , 1958 .
[13] L. Stewart,et al. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. , 1995, Statistics in medicine.
[14] N. Kawasaki,et al. Role of preoperative chemotherapy for non-small-cell lung cancer: a meta-analysis. , 2006, Lung cancer.
[15] J. Roth,et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. , 1994, Journal of the National Cancer Institute.
[16] KyungMann Kim,et al. Contrasting treatment‐specific survival using double‐robust estimators , 2012 .
[17] Wen Gao,et al. [A clinicopathologic study on neoadjuvant chemotherapy in the treatment of non-small-cell lung cancer]. , 2003, Zhongguo fei ai za zhi = Chinese journal of lung cancer.
[18] M. Parmar,et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[19] F. Song,et al. Preoperative versus Postoperative Chemotherapy in Patients with Resectable Non-small Cell Lung Cancer: Systematic Review and Indirect Comparison Meta-Analysis of Randomized Trials , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[20] O. Dalesio,et al. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review , 2007, The Lancet.
[21] J. Lafitte,et al. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature. , 2005, Lung cancer.
[22] Yang Liu,et al. Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[23] B. Lahiri,et al. Preoperative evaluation of patients undergoing lung resection surgery. , 2003, Chest.
[24] J. Crowley,et al. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] U. Pastorino,et al. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial , 1999, British Journal of Cancer.
[26] Yi-long Wu,et al. P-645 A randomized trial comparing neoadjuvant gemicitabine plus carboplatin or cisplatin followed by surgery with surgery alone in Clinical Stage IIIA non-small-cell lung cancer (NSCLC) , 2005 .
[27] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[28] F. Schmidt. Meta-Analysis , 2008 .
[29] L. Stewart,et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data , 2010, The Lancet.
[30] S. Steinberg,et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. , 1992, The Annals of thoracic surgery.
[31] L. Stewart,et al. A Systematic Review and Meta-analysis of the Literature: Chemotherapy and Surgery versus Surgery Alone in Non-small Cell Lung Cancer , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[32] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[33] Chronic Disease Division. Cancer facts and figures , 2010 .
[34] E. Lemarié,et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[36] B. Nathwani,et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[37] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[38] M. Parmar,et al. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.
[39] J. Benichou,et al. Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non‐small cell carcinoma results from a randomized phase II trial , 1990, Cancer.
[40] E. Smit,et al. Randomized multicenter phase II study of chemotherapy followed by surgery versus surgery alone in stage I and II non-small cell lung cancer (NSCLC) , 2000 .
[41] W. Allum,et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] H. Pilegaard,et al. Scandinavian phase III trial of neoadjuvant chemotherapy in NSCLC stages IB-IIIA/T3 , 2005 .
[43] J F Tierney,et al. A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners. , 2011, Journal of clinical epidemiology.
[44] J. Padilla,et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] M. Parmar,et al. Meta-analysis of the literature or of individual patient data: is there a difference? , 1993, The Lancet.
[46] M Schemper,et al. A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.